Skip to content

Evaluating a Chronic Pain Treatment Program

Evaluating Outcomes and Response Profiles of a Psychological Treatment for People With Chronic Pain

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00861302
Enrollment
72
Registered
2009-03-13
Start date
2008-09-30
Completion date
2011-11-30
Last updated
2012-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Musculoskeletal Pain

Brief summary

This interventional study seeks to evaluate the overall outcomes of a novel, emotional awareness intervention for people with chronic musculoskeletal pain and determine which patients benefit the most from this intervention. The investigators also are evaluating the effects of brief emotional communication technique embedded in the pre-treatment assessment.

Interventions

BEHAVIORALMind-body emotional awareness program

This intervention, developed and offered by Dr. Howard Schubiner of St. John Providence Health System, consists of a single individual session with him, followed by four, classroom group sessions. The intervention includes expressive writing, mindfulness, and other techniques designed to enhance awareness and acceptance of the emotional factors underlying the chronic pain problem.

Sponsors

Blue Cross Blue Shield of Michigan Foundation
CollaboratorOTHER
Wayne State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with chronic musculoskeletal pain, not accounted for by disease or tissue pathology, who are seeking or referred for this psychological treatment program

Exclusion criteria

* Autoimmune diseases * Cancer pain * Illiterate * Cognitively impaired * Too medically ill

Design outcomes

Primary

MeasureTime frame
Brief Pain Inventorybaseline, post-treatment, 3- and 6-month follow-ups

Secondary

MeasureTime frame
Center for Epidemiologic Studies--Depression Scalebaseline, post-treatment, 3- and 6-month follow-ups
McGill Pain Questionnairebaseline, post-treatment, 3- and 6-month follow-ups
Impact of Events Scale-Revisedbaseline, post-treatment, 3- and 6-month follow-ups
Satisfaction with Life Scalebaseline, post-treatment, 3- and 6-month follow-ups
Positive Affect Negative Affect Scale-Expanded Versionbaseline, post-treatment, 3- and 6-month follow-ups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026